Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum reverse T3 and amiodarone efficacy.

R J Haberman1, P W Ladenson, L S Griffith

  • 1Department of Medicine, Sinai Hospital, Baltimore, MD 21215.

Clinical Cardiology
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of Thyroid Cancer Among Solid Organ Transplant Recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

The impact of age and gender on papillary thyroid cancer survival.

The Journal of clinical endocrinology and metabolism·2012
Same author

Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study.

The Journal of clinical endocrinology and metabolism·2010
Same author

Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.

The Journal of clinical endocrinology and metabolism·2009
Same author

Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.

Journal of lipid research·2009
Same author

Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.

The Journal of clinical endocrinology and metabolism·2009
Same journal

Comparing Ferric Carboxymaltose Versus Iron Sucrose in Patients with Heart Failure.

Clinical cardiology·2026
Same journal

Beyond Rural Versus Urban: Referral Pathways and Structural Heart Programs May Influence Outcomes After Left Atrial Appendage Occlusion.

Clinical cardiology·2026
Same journal

Strauss-Defined LBBB Identifies Patients With Improved Outcomes After CRT-D: A Comparative Cohort Study.

Clinical cardiology·2026
Same journal

Does Serum γKlotho Truly Provide Incremental Prognostic Value Beyond Established Risk Predictors in Multivessel Coronary Artery Disease?

Clinical cardiology·2026
Same journal

Associations of the C-Reactive Protein-Albumin-Lymphocyte Index, Red Cell Distribution Width-Albumin Ratio, and Blood Urea Nitrogen-Albumin Ratio With All-Cause and Cardiovascular Mortality Among Adults With Preclinical Heart Failure.

Clinical cardiology·2026
Same journal

Real-World National Databases Versus Hypothesis-Driven Cohort Studies: A Reply to the Critique on the TURK-HF Registry Design.

Clinical cardiology·2026
See all related articles

Serum reverse T3 (rT3) levels do not reliably predict amiodarone

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Amiodarone is an effective antiarrhythmic drug used for ventricular tachycardia (VT).
  • The role of serum reverse triiodothyronine (rT3) in assessing amiodarone efficacy remains debated.
  • Thyroid function tests, including rT3, are often monitored during amiodarone therapy.

Purpose of the Study:

  • To prospectively evaluate the correlation between serum rT3 levels and amiodarone's efficacy in suppressing ventricular arrhythmias.
  • To determine if rT3 levels can predict treatment response in patients with frequent ventricular ectopy and VT.

Main Methods:

  • Prospective study of 10 patients with symptomatic VT treated with oral amiodarone.
  • Serial 24-hour Holter monitoring, thyroid function tests (including serum rT3), and ECGs were performed at baseline and 1, 4, 12, and 24 weeks.

Related Experiment Videos

  • Patients were categorized based on the degree of suppression of VT, couplets (Co), and ventricular ectopic beats (VEBs).

    • Main Results:

    • No statistically significant differences in serum rT3 levels were observed between groups with and without arrhythmia suppression (VT+ vs. VT-, Co+ vs. Co-, VEB+ vs. VEB-).
    • Serum rT3 levels did not predict VT suppression at any time point during the study.
    • Individual patient responses in arrhythmia suppression did not correlate with changes in rT3 levels.

    Conclusions:

    • Serum reverse T3 is an insensitive marker for assessing the efficacy of amiodarone in patients with ventricular arrhythmias.
    • Clinical arrhythmia burden, rather than rT3 levels, should guide therapeutic decisions for amiodarone treatment.
    • Further research may be needed to identify reliable biomarkers for amiodarone response.